Industries > Pharma > Global Diagnostic Imaging Market Forecast 2019-2029

Global Diagnostic Imaging Market Forecast 2019-2029

MRI Systems, Ultrasound Imaging Systems, CT Scanners, Nuclear Imaging, X-Ray Imaging, Mammography, Cardiology, Gynecology/Obs, Orthopaedics & Musculoskeletal, Radiology, Neurology & Spine, General Imaging, Hospitals, Diagnostic Imaging Centers

PUBLISHED: 20 September 2019
PAGES: 257
PRODUCT CODE: PHA0523
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0523 Categories: , Tags: , , , , ,

The global diagnostic imaging market is estimated to have reached $24.1bn in 2018. Ultrasound Imaging Systems segment held the largest market share of the global diagnostic imaging market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 257-page report you will receive 104 tables and 153 figures– all unavailable elsewhere.

The 257-page report provides clear detailed insight into the global diagnostic imaging market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Diagnostic Imaging Market forecasts from 2019-2029

• Global Diagnostic Imaging Market forecasts from 2019-2029 by Product Type:
• MRI Systems Products Type Segment
• Ultrasound Imaging Systems Segment
• CT Scanners Segment
• Nuclear Imaging Systems Segment
• X-Ray Imaging Systems Segment
• Mammography Systems Segment

Global Diagnostic Imaging Market Forecast 2019-2029

• Global Diagnostic Imaging Market forecasts from 2019-2029 by Application:
• Cardiology Segment
• Gynecology/Obs Segment
• Orthopaedics & Musculoskeletal Segment
• Radiology Segment
• Neurology & Spine Segment
• General Imaging Segment
• Others Segment

• Global Diagnostic Imaging Market forecasts from 2019-2029 by End-User:
• Hospitals Segment
• Diagnostic Imaging Centers Segment
• Others Segment

• Revenue forecasts for the Diagnostic Imaging Market by Regional and National Market from 2019-2029:
• North America: US, Canada
• Europe: UK, France, Germany, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East and Africa (MEA): GCC Countries, South Africa, North Africa, Rest of MEA

The revenues forecast of each regional market is further broken down by product type, application and end-user.

• Profiles and discussion on the leading companies of the diagnostic imaging market:
• Canon, Inc.
• Carestream Health, Inc.
• Esaote SPA
• FUJIFILM Holdings Corporation
• GE Healthcare
• Hitachi, Ltd.
• Koninklijke Philips N.V. (Royal Philips)
• Samsung Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG

• Analysis of the Drivers, Restraints, Opportunities and Trends of the diagnostic imaging market.

• Key Questions Answered by this Report:
• How is the diagnostic imaging market evolving?
• What is driving and restraining diagnostic imaging market dynamics?
• How will each diagnostic imaging submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2029?
• How will market shares of each diagnostic imaging submarket develop from 2019-2029?
• Which individual technologies will prevail and how will these shifts be responded to?
• Which diagnostic imaging submarket will be the main driver of the overall market from 2019-2029?
• Will leading national diagnostic imaging markets broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
• How will market shares of the national markets change by 2029 and which nation will lead the market in 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the sector evolve as alliances form during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Diagnostic Imaging Market. You find data, trends and predictions.

Buy our report today Global Diagnostic Imaging Market Forecast 2019-2029: MRI Systems, Ultrasound Imaging Systems, CT Scanners, Nuclear Imaging, X-Ray Imaging, Mammography, Cardiology, Gynecology/Obs, Orthopaedics & Musculoskeletal, Radiology, Neurology & Spine, General Imaging, Hospitals, Diagnostic Imaging Centers.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Diagnostic Imaging Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Diagnostic Imaging Market Forecast 2019-2029


Latest Pharma news

Pharmaceutical CDMO Services on the Rise

The pharmaceutical market is one of today’s fastest-growing industries, which is why the professionals from Visiongain have made it their business to help companies and stakeholders stay up to date. One sector experiencing significant growth is that of contract development and manufacturing organization (CDMO) services. Here you’ll find all you need to know about this fast-growing sector of the pharmaceutical …

24 February 2020

READ

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

READ

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

READ

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

READ

Categories

Category